Evaluation of PCR to monitor Plasmodium falciparum treatment efficacy in a non-endemic setting.
Adequate Clinical and Parasitological Response (ACPR) after malaria treatment remains challenging to assess in non-malaria endemic settings. Biological evaluation of parasitological clearance relies on microscopic investigation of thick blood smears, which is a specific technique that not all diagnosis laboratories are able to perform. Rapid Diagnosis Tests (RDT) and molecular biology techniques are proposed as alternatives to microscope conventional techniques, however, their performance for treatment efficacy evaluation are controversial. We present here a retrospective comparative study for RDT and PCR (nested and HRM-qPCR) evaluation of ACPR in a non-endemic context. Blood samples from 133 patients presenting a mono-specific Plasmodium falciparum infection were included. Samples obtained at the diagnosis and three, seven and 28 days post diagnosis were investigated. HRP-2 based RDT remained positive in 51% of cases 28 days after diagnosis and appropriate therapeutic management. Parasite DNA was detected by the two PCR techniques (nested-PCR and HRM-qPCR) in 12 % and 10 % of samples 28 days after treatment initiation respectively. No therapeutic failure was recorded in the studied patients. Persistence of positive signal might be the reflection of circulating asexual parasites, or persistence of HRP-2 and parasitic DNA in patient's peripheral blood after parasitic clearance.